Artur / iStockphoto.com
28 January 2019Americas
Merck signs DNA licensing deal with Vertex
German pharmaceutical company Merck Group has granted US biotech firm Vertex a licence to two DNA-dependent protein kinases (DNA-PK) inhibitors.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Big Pharma
13 December 2018 France-based biotechnology company genOway has acquired the exclusive global rights to German pharmaceutical company Merck Group’s CRISPR patents, to be used in the production and sale of rodent models.
Big Pharma
11 March 2019 King’s College London has entered a licensing and collaboration agreement with US pharmaceutical company Merck & Co to develop new chronic pain medications.
Editor's picks
Editor's picks
Big Pharma
13 December 2018 France-based biotechnology company genOway has acquired the exclusive global rights to German pharmaceutical company Merck Group’s CRISPR patents, to be used in the production and sale of rodent models.
Big Pharma
11 March 2019 King’s College London has entered a licensing and collaboration agreement with US pharmaceutical company Merck & Co to develop new chronic pain medications.
Big Pharma
13 December 2018 France-based biotechnology company genOway has acquired the exclusive global rights to German pharmaceutical company Merck Group’s CRISPR patents, to be used in the production and sale of rodent models.
Big Pharma
11 March 2019 King’s College London has entered a licensing and collaboration agreement with US pharmaceutical company Merck & Co to develop new chronic pain medications.